Dermatan sulfate: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447549315
| image = Dermatan Wiki Str.png
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|dermatan-sulfate}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 24967-94-0
| ATC_prefix = B01
| ATC_suffix = AX04
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 30361
<!--Chemical data-->
| C = 14 |H = 21 |N = 1 |O = 15 |S = 2
| molecular_weight =
| smiles = [O-]C(=O)[C@@H]2O[C@@H](O[C@H]1[C@@H](OS([O-])(=O)=O)[C@H](O[C@@H](O)[C@@H]1NC(=O)C)CO)[C@H](O)[C@@H](O)[C@@H]2O
| InChI = 1/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1
| InChIKey = AVJBPWGFOQAPRH-SRMSFAINBD
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1909290
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AVJBPWGFOQAPRH-FWMKGIEWSA-L
}}
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
Line 29: Line 70:
{{Glycosaminoglycans}}
{{Glycosaminoglycans}}


[[Category:drug]]
[[Category:Glycosaminoglycans]]
[[Category:Glycosaminoglycans]]

Latest revision as of 16:03, 14 April 2015

Dermatan sulfate
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H21NO15S2
Molar mass507.43 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)


WikiDoc Resources for Dermatan sulfate

Articles

Most recent articles on Dermatan sulfate

Most cited articles on Dermatan sulfate

Review articles on Dermatan sulfate

Articles on Dermatan sulfate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dermatan sulfate

Images of Dermatan sulfate

Photos of Dermatan sulfate

Podcasts & MP3s on Dermatan sulfate

Videos on Dermatan sulfate

Evidence Based Medicine

Cochrane Collaboration on Dermatan sulfate

Bandolier on Dermatan sulfate

TRIP on Dermatan sulfate

Clinical Trials

Ongoing Trials on Dermatan sulfate at Clinical Trials.gov

Trial results on Dermatan sulfate

Clinical Trials on Dermatan sulfate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dermatan sulfate

NICE Guidance on Dermatan sulfate

NHS PRODIGY Guidance

FDA on Dermatan sulfate

CDC on Dermatan sulfate

Books

Books on Dermatan sulfate

News

Dermatan sulfate in the news

Be alerted to news on Dermatan sulfate

News trends on Dermatan sulfate

Commentary

Blogs on Dermatan sulfate

Definitions

Definitions of Dermatan sulfate

Patient Resources / Community

Patient resources on Dermatan sulfate

Discussion groups on Dermatan sulfate

Patient Handouts on Dermatan sulfate

Directions to Hospitals Treating Dermatan sulfate

Risk calculators and risk factors for Dermatan sulfate

Healthcare Provider Resources

Symptoms of Dermatan sulfate

Causes & Risk Factors for Dermatan sulfate

Diagnostic studies for Dermatan sulfate

Treatment of Dermatan sulfate

Continuing Medical Education (CME)

CME Programs on Dermatan sulfate

International

Dermatan sulfate en Espanol

Dermatan sulfate en Francais

Business

Dermatan sulfate in the Marketplace

Patents on Dermatan sulfate

Experimental / Informatics

List of terms related to Dermatan sulfate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dermatan sulfate is a glycosaminoglycan (formerly called a mucopolysaccharide) found mostly in skin, but also in blood vessels, heart valves, tendons, and lungs.

It is also referred to as chondroitin sulfate B, [1] although it is no longer classified as a form of chondroitin sulfate by most sources.

Function

Dermatan sulfate may have roles in coagulation, cardiovascular disease, carcinogenesis, infection, wound repair, and fibrosis.

Pathology

Dermatan sulfate accumulates abnormally in several of the mucopolysaccharidosis disorders.

An excess of Dermatan Sulfate in the Mitral Valve is characteristic of myxomatous degeneration of the leaflets leading to redundancy of valve tissue and ultimately, Mitral Valve Prolapse (into the Left Ventricle) and insufficiency. This chronic prolapse occurs mainly in women over the age of 60, and can predispose the patient to mitral annular calcification and eccentric (volume dependent or dilated) hypertrophy and eventually Left Heart failure if untreated. Also used to treat sun burns.

See Also

External Links

References

  1. Trowbridge, JM (2002 Sep). "Dermatan sulfate: new functions from an old glycosaminoglycan". Glycobiology. 12 (9): 117R–25R. PMID 12213784. Unknown parameter |coauthors= ignored (help); Check date values in: |date= (help)

Template:Glycosaminoglycans